img

Global End-Stage Renal Disease (ESRD) Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global End-Stage Renal Disease (ESRD) Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

End-Stage Renal Disease (ESRD) Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global End-Stage Renal Disease (ESRD) Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for End-Stage Renal Disease (ESRD) Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, End-Stage Renal Disease (ESRD) Drugs key manufacturers include CTI BioPharma Corp, Merck & Co Inc, Novartis AG, Prolong Pharmaceuticals LLC and VESSL Therapeutics Ltd, etc. CTI BioPharma Corp, Merck & Co Inc, Novartis AG are top 3 players and held % sales share in total in 2022.
End-Stage Renal Disease (ESRD) Drugs can be divided into Calcium Succinate, Mk-3866, Pacritinib and Sanguinate, etc. Calcium Succinate is the mainstream product in the market, accounting for % sales share globally in 2022.
End-Stage Renal Disease (ESRD) Drugs is widely used in various fields, such as Hospital, Clinic, ICU and Others, etc. Hospital provides greatest supports to the End-Stage Renal Disease (ESRD) Drugs industry development. In 2022, global % sales of End-Stage Renal Disease (ESRD) Drugs went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global End-Stage Renal Disease (ESRD) Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CTI BioPharma Corp
Merck & Co Inc
Novartis AG
Prolong Pharmaceuticals LLC
VESSL Therapeutics Ltd
Segment by Type
Calcium Succinate
Mk-3866
Pacritinib
Sanguinate
Tesidolumab
Others

Segment by Application


Hospital
Clinic
ICU
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the End-Stage Renal Disease (ESRD) Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of End-Stage Renal Disease (ESRD) Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the End-Stage Renal Disease (ESRD) Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of End-Stage Renal Disease (ESRD) Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, End-Stage Renal Disease (ESRD) Drugs introduction, etc. End-Stage Renal Disease (ESRD) Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of End-Stage Renal Disease (ESRD) Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 End-Stage Renal Disease (ESRD) Drugs Market Overview
1.1 End-Stage Renal Disease (ESRD) Drugs Product Overview
1.2 End-Stage Renal Disease (ESRD) Drugs Market Segment by Type
1.2.1 Calcium Succinate
1.2.2 Mk-3866
1.2.3 Pacritinib
1.2.4 Sanguinate
1.2.5 Tesidolumab
1.2.6 Others
1.3 Global End-Stage Renal Disease (ESRD) Drugs Market Size by Type
1.3.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global End-Stage Renal Disease (ESRD) Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2018-2024)
2 Global End-Stage Renal Disease (ESRD) Drugs Market Competition by Company
2.1 Global Top Players by End-Stage Renal Disease (ESRD) Drugs Sales (2018-2024)
2.2 Global Top Players by End-Stage Renal Disease (ESRD) Drugs Revenue (2018-2024)
2.3 Global Top Players by End-Stage Renal Disease (ESRD) Drugs Price (2018-2024)
2.4 Global Top Manufacturers End-Stage Renal Disease (ESRD) Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 End-Stage Renal Disease (ESRD) Drugs Market Competitive Situation and Trends
2.5.1 End-Stage Renal Disease (ESRD) Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by End-Stage Renal Disease (ESRD) Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in End-Stage Renal Disease (ESRD) Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into End-Stage Renal Disease (ESRD) Drugs Market
2.8 Key Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 End-Stage Renal Disease (ESRD) Drugs Status and Outlook by Region
3.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global End-Stage Renal Disease (ESRD) Drugs Historic Market Size by Region
3.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global End-Stage Renal Disease (ESRD) Drugs Sales in Value by Region (2018-2024)
3.2.3 Global End-Stage Renal Disease (ESRD) Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Market Size by Region
3.3.1 Global End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global End-Stage Renal Disease (ESRD) Drugs Sales in Value by Region (2024-2034)
3.3.3 Global End-Stage Renal Disease (ESRD) Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global End-Stage Renal Disease (ESRD) Drugs by Application
4.1 End-Stage Renal Disease (ESRD) Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 ICU
4.1.4 Others
4.2 Global End-Stage Renal Disease (ESRD) Drugs Market Size by Application
4.2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global End-Stage Renal Disease (ESRD) Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global End-Stage Renal Disease (ESRD) Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2018-2024)
5 North America End-Stage Renal Disease (ESRD) Drugs by Country
5.1 North America End-Stage Renal Disease (ESRD) Drugs Historic Market Size by Country
5.1.1 North America End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America End-Stage Renal Disease (ESRD) Drugs Sales in Value by Country (2018-2024)
5.2 North America End-Stage Renal Disease (ESRD) Drugs Forecasted Market Size by Country
5.2.1 North America End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America End-Stage Renal Disease (ESRD) Drugs Sales in Value by Country (2024-2034)
6 Europe End-Stage Renal Disease (ESRD) Drugs by Country
6.1 Europe End-Stage Renal Disease (ESRD) Drugs Historic Market Size by Country
6.1.1 Europe End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe End-Stage Renal Disease (ESRD) Drugs Sales in Value by Country (2018-2024)
6.2 Europe End-Stage Renal Disease (ESRD) Drugs Forecasted Market Size by Country
6.2.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe End-Stage Renal Disease (ESRD) Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs by Region
7.1 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Historic Market Size by Region
7.1.1 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales in Value by Region (2024-2034)
8 Latin America End-Stage Renal Disease (ESRD) Drugs by Country
8.1 Latin America End-Stage Renal Disease (ESRD) Drugs Historic Market Size by Country
8.1.1 Latin America End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America End-Stage Renal Disease (ESRD) Drugs Sales in Value by Country (2018-2024)
8.2 Latin America End-Stage Renal Disease (ESRD) Drugs Forecasted Market Size by Country
8.2.1 Latin America End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America End-Stage Renal Disease (ESRD) Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs by Country
9.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Historic Market Size by Country
9.1.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 CTI BioPharma Corp
10.1.1 CTI BioPharma Corp Company Information
10.1.2 CTI BioPharma Corp Introduction and Business Overview
10.1.3 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Products Offered
10.1.5 CTI BioPharma Corp Recent Development
10.2 Merck & Co Inc
10.2.1 Merck & Co Inc Company Information
10.2.2 Merck & Co Inc Introduction and Business Overview
10.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Products Offered
10.2.5 Merck & Co Inc Recent Development
10.3 Novartis AG
10.3.1 Novartis AG Company Information
10.3.2 Novartis AG Introduction and Business Overview
10.3.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis AG End-Stage Renal Disease (ESRD) Drugs Products Offered
10.3.5 Novartis AG Recent Development
10.4 Prolong Pharmaceuticals LLC
10.4.1 Prolong Pharmaceuticals LLC Company Information
10.4.2 Prolong Pharmaceuticals LLC Introduction and Business Overview
10.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Products Offered
10.4.5 Prolong Pharmaceuticals LLC Recent Development
10.5 VESSL Therapeutics Ltd
10.5.1 VESSL Therapeutics Ltd Company Information
10.5.2 VESSL Therapeutics Ltd Introduction and Business Overview
10.5.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Products Offered
10.5.5 VESSL Therapeutics Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 End-Stage Renal Disease (ESRD) Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 End-Stage Renal Disease (ESRD) Drugs Industrial Chain Analysis
11.4 End-Stage Renal Disease (ESRD) Drugs Market Dynamics
11.4.1 End-Stage Renal Disease (ESRD) Drugs Industry Trends
11.4.2 End-Stage Renal Disease (ESRD) Drugs Market Drivers
11.4.3 End-Stage Renal Disease (ESRD) Drugs Market Challenges
11.4.4 End-Stage Renal Disease (ESRD) Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 End-Stage Renal Disease (ESRD) Drugs Distributors
12.3 End-Stage Renal Disease (ESRD) Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Calcium Succinate
Table 2. Major Company of Mk-3866
Table 3. Major Company of Pacritinib
Table 4. Major Company of Sanguinate
Table 5. Major Company of Tesidolumab
Table 6. Major Company of Others
Table 7. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2018-2024) & (K Pcs)
Table 9. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type (2018-2024)
Table 10. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2018-2024) & (US& Million)
Table 11. Global End-Stage Renal Disease (ESRD) Drugs Market Share in Value by Type (2018-2024)
Table 12. Global End-Stage Renal Disease (ESRD) Drugs Price by Type (2018-2024) & (USD/Pcs)
Table 13. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2024-2034) & (K Pcs)
Table 14. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type (2024-2034)
Table 15. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2024-2034) & (US$ Million)
Table 16. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type (2024-2034)
Table 17. Global End-Stage Renal Disease (ESRD) Drugs Price by Type (2024-2034) & (USD/Pcs)
Table 18. North America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2018-2024) & (K Pcs)
Table 19. North America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Type (2018-2024)
Table 21. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Type (2018-2024)
Table 23. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Type (2018-2024)
Table 25. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Type (2018-2024)
Table 27. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 28. Global End-Stage Renal Disease (ESRD) Drugs Sales by Company (2018-2024) & (K Pcs)
Table 29. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Company (2018-2024)
Table 30. Global End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Company (2018-2024)
Table 32. Global Market End-Stage Renal Disease (ESRD) Drugs Price by Company (2018-2024) & (USD/Pcs)
Table 33. Global End-Stage Renal Disease (ESRD) Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global End-Stage Renal Disease (ESRD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in End-Stage Renal Disease (ESRD) Drugs as of 2022)
Table 36. Date of Key Manufacturers Enter into End-Stage Renal Disease (ESRD) Drugs Market
Table 37. Key Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global End-Stage Renal Disease (ESRD) Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2018-2024) & (K Pcs)
Table 41. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Region (2018-2024)
Table 42. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2018-2024) & (US$ Million)
Table 43. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Region (2018-2024)
Table 44. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 45. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2024-2034) & (K Pcs)
Table 46. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Region (2024-2034)
Table 47. Global End-Stage Renal Disease (ESRD) Drugs Sales by Region (2024-2034) & (US$ Million)
Table 48. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Region (2024-2034)
Table 49. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 50. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) & (K Pcs)
Table 52. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application (2018-2024)
Table 53. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 54. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application (2018-2024)
Table 55. Global End-Stage Renal Disease (ESRD) Drugs Price by Application (2018-2024) & (USD/Pcs)
Table 56. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2024-2034) & (K Pcs)
Table 57. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application (2024-2034)
Table 58. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2024-2034) & (US$ Million)
Table 59. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application (2024-2034)
Table 60. Global End-Stage Renal Disease (ESRD) Drugs Price by Application (2024-2034) & (USD/Pcs)
Table 61. North America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) (K Pcs)
Table 62. North America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) (K Pcs)
Table 64. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) (K Pcs)
Table 66. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) (K Pcs)
Table 68. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) (K Pcs)
Table 70. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 71. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2024) & (K Pcs)
Table 72. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 73. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 74. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Country (2018-2024)
Table 75. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2034) & (K Pcs)
Table 76. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 77. North America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 78. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Country (2024-2034)
Table 79. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2024) & (K Pcs)
Table 80. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Country (2018-2024)
Table 83. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2034) & (K Pcs)
Table 84. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2018-2024) & (K Pcs)
Table 88. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2024-2034) & (K Pcs)
Table 92. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2024) & (K Pcs)
Table 96. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2034) & (K Pcs)
Table 100. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2024) & (K Pcs)
Table 104. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2034) & (K Pcs)
Table 108. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Country (2024-2034)
Table 111. CTI BioPharma Corp Company Information
Table 112. CTI BioPharma Corp Introduction and Business Overview
Table 113. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 114. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product
Table 115. CTI BioPharma Corp Recent Development
Table 116. Merck & Co Inc Company Information
Table 117. Merck & Co Inc Introduction and Business Overview
Table 118. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 119. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product
Table 120. Merck & Co Inc Recent Development
Table 121. Novartis AG Company Information
Table 122. Novartis AG Introduction and Business Overview
Table 123. Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 124. Novartis AG End-Stage Renal Disease (ESRD) Drugs Product
Table 125. Novartis AG Recent Development
Table 126. Prolong Pharmaceuticals LLC Company Information
Table 127. Prolong Pharmaceuticals LLC Introduction and Business Overview
Table 128. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 129. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product
Table 130. Prolong Pharmaceuticals LLC Recent Development
Table 131. VESSL Therapeutics Ltd Company Information
Table 132. VESSL Therapeutics Ltd Introduction and Business Overview
Table 133. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 134. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product
Table 135. VESSL Therapeutics Ltd Recent Development
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. End-Stage Renal Disease (ESRD) Drugs Market Trends
Table 139. End-Stage Renal Disease (ESRD) Drugs Market Drivers
Table 140. End-Stage Renal Disease (ESRD) Drugs Market Challenges
Table 141. End-Stage Renal Disease (ESRD) Drugs Market Restraints
Table 142. End-Stage Renal Disease (ESRD) Drugs Distributors List
Table 143. End-Stage Renal Disease (ESRD) Drugs Downstream Customers
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. End-Stage Renal Disease (ESRD) Drugs Product Picture
Figure 2. Global End-Stage Renal Disease (ESRD) Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global End-Stage Renal Disease (ESRD) Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global End-Stage Renal Disease (ESRD) Drugs Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Calcium Succinate
Figure 6. Global Calcium Succinate Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Mk-3866
Figure 8. Global Mk-3866 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Pacritinib
Figure 10. Global Pacritinib Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Sanguinate
Figure 12. Global Sanguinate Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Tesidolumab
Figure 14. Global Tesidolumab Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2022 & 2034
Figure 19. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type in 2022
Figure 20. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type in 2022
Figure 21. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type in 2022
Figure 25. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by End-Stage Renal Disease (ESRD) Drugs Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by End-Stage Renal Disease (ESRD) Drugs Revenue in 2022
Figure 31. End-Stage Renal Disease (ESRD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Clinic
Figure 35. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of ICU
Figure 37. Global ICU Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Global End-Stage Renal Disease (ESRD) Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2022 & 2034
Figure 42. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application in 2022
Figure 43. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application in 2022
Figure 44. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application in 2022
Figure 45. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application in 2022
Figure 48. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Volume by Application in 2022
Figure 49. Latin America End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. End-Stage Renal Disease (ESRD) Drugs Manufacturing Cost Structure
Figure 53. End-Stage Renal Disease (ESRD) Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries